Nutrigenomics And Children Obesity: A Moderate Weight Loss Intervention Study

Not Applicable

Completed

• Conditions: Obesity
• Interventions: Behavioral: Antioxidant group; Behavioral: Control group; Behavioral: Protein group

• Registration Number: NCT01329367
• Lead Sponsor: Clinica Universidad de Navarra, Universidad de Navarra

Brief Summary

The consumption of diets enriched in proteins (legumes and fish) or antioxidant (fruits and vegetables) could have beneficial effects beyond those of the caloric restriction on biomarkers of the inflammatory and oxidative status. OBJECTIVE: To address the effect of a 10-week dietary intervention aimed to weight loss in obese or overweight children (7-15 aged) on genomics, particularly the changes in the expression of genes related to the inflammatory status and oxidative stress. METHODOLOGY: 44 Navarra children and adolescents of both sexes from Pediatric Endocrinology Services at different Hospitals in Pamplona will be recruited. The effect of the intensive consumption of different groups of food will be evaluated: legumes and fish ( diets in proteins) and vegetable and fruits (rich diets in antioxidants). Before and after the intervention, the following items will be analyzed: (1) the diet of the subjects, (2) body composition and 3 magnitudes related to biological and development parameters, being: (3) lipid and metabolic phenotypic profile; (4) markers of the inflammatory status and oxidative stress, and (5) the genomic profile. The dietary programme will be implemented both in group workshops addresseded to patients and their family, and in individual sessions with the pediatricians and/or registered dieticians. Finally, the programme efficacy will be evaluated by the scoreboards integrated in the 5 variables already mentioned.

Detailed Description

A longitudinal intervention study in 44 overweight and obese adolescents (23 females and 21 males; mean age 11.5 years) for 10 weeks based on a calorie restricted diet (20-40%) according to obesity degree.

Study Timeline

• Study Start: 2010-01
• Study First Submitted: 2011-01-20
• Study First Submitted QC: 2011-04-04
• Study First Posted: 2011-04-05
• Primary Completion: 2011-09
• Status Verified: 2020-03
• Study Completion: 2020-03
• Last Update Submitted: 2020-03-23
• Last Update Posted: 2020-03-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

• Children between 7 and 15 years

• Body Mass Index (BMI) higher to 97 percentile. (Cole et al, 2000)*

  • Cole TJ, Belizzy MC, Flegal KM, Dietz WH. Br Med J 2000; 320: 1-6.

Exclusion Criteria

• Use of prescription medication
• To suffer from any major psychiatry or neurological disease, bulimia nervosa, familiar hypercholesterolemia or any major cardiac, or respiratory metabolic disease.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Antioxidant group	Antioxidant group	Antioxidant group: Participants will receive Nutritional education and personalized structured meal plan with a calorie restricted diet (20-40% of the subject's energy expenditure at baseline) according to obesity degree, encouraging high consumption of fruits and vegetables (antioxidant rich diets). -10 weekly personal interviews with a registered nutritionist for body weight control.
Control group	Control group	Control group: Subjects will receive Nutritional education together with weight management counselling for overweight and obesity. -10 weekly personal interviews with a registered nutritionist for body weight control.
Protein group	Protein group	Protein group: Participants will receive Nutritional education and personalised structured meal plan with a calorie restricted diet (20-40% of the subject's energy expenditure at baseline) according to obesity degree, encouraging high consumption of legumes and fish (protein rich diets). -10 weekly personal interviews with a registered nutritionist for body weight control.

Primary Outcome Measures

Name	Time	Method
Body masss index	week 0	Body mas index will be measured at the beginning of the study (week 0), at week 5 and week 10 (end of the study).

Secondary Outcome Measures

Name	Time	Method
Basal glucose concentration	week 10	Basal glucose concentration will be measured at the beginning of the study (week 0)and week 10 (end of the study).
Insulin concentrations	week 0	Insulin concentrations will be analysed at week 0, and 10.

Trial Locations

Locations (2)

UNavarre; 🇪🇸 Pamplona, Navarra, Spain

University of Navarre; 🇪🇸 Pamplona, Navarra, Spain